U.S. Markets closed
  • S&P Futures

    4,165.50
    -10.75 (-0.26%)
     
  • Dow Futures

    33,980.00
    -101.00 (-0.30%)
     
  • Nasdaq Futures

    14,003.00
    -26.50 (-0.19%)
     
  • Russell 2000 Futures

    2,259.00
    +3.30 (+0.15%)
     
  • Crude Oil

    62.80
    -0.33 (-0.52%)
     
  • Gold

    1,780.40
    +0.20 (+0.01%)
     
  • Silver

    25.98
    -0.12 (-0.48%)
     
  • EUR/USD

    1.1957
    -0.0023 (-0.1913%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • Vix

    16.25
    -0.32 (-1.93%)
     
  • GBP/USD

    1.3815
    -0.0025 (-0.1796%)
     
  • USD/JPY

    108.7280
    -0.0550 (-0.0506%)
     
  • BTC-USD

    56,864.77
    -4,072.89 (-6.68%)
     
  • CMC Crypto 200

    1,288.81
    -102.90 (-7.39%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,673.05
    -10.32 (-0.03%)
     

Novanta to Present at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chief Executive Officer, is scheduled to present at the J.P. Morgan Healthcare Conference, which is being held virtually, on Wednesday, January 13, 2021.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ("OEMs") a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers’ demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol "NOVT".

More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201215005017/en/

Contacts

Novanta Inc.
Investor Relations:
Ray Nash
(781) 266-5137